Skip to content
Screener

LifeVantage Corporation LFVN Q4 2026 Annual earnings

Reported August 27, 2026 · After market close

Revenue$42.4MMiss by $1.6M
EPS$0.11Miss by $0.01
Revenue estimate$44.0M
EPS estimate$0.12
“It's a privilege to lead LifeVantage at this stage of its journey and my conviction about this Company is stronger today than when I accepted the role. With a differentiated, science-backed platform, strong gross margins and a debt-free balance sheet, our foundation is strong and I believe we have a real competitive advantage. Our early focus will be on strengthening the LifeVantage brand, building a more relevant consumer proposition, and driving operational excellence. Despite the challenges reflected in our recent results, I'm optimistic about what lies ahead. We intend to move forward with a real sense of urgency and look forward to sharing more about our strategy as our work progresses.”
Terrence Moorehead

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$40.5M
EPS estimate$0.03

Financials

Q4 2026

Income statement

See full
Revenue$42.4M-23.1%
Gross profit$33.0M-25.0%
Operating income$1.7M-22.4%
Net income$1.3M-34.7%
EPS (diluted)$0.10-33.3%

Balance sheet

See full
Cash & equivalents$14.9M-26.1%
Total debt$9.9M-15.5%
Total equity$33.6M-3.0%
Total assets$62.1M-13.7%

Cash flow

See full
Operating cash flow$4.8M+361%
CapEx$1.0M+421%
Free cash flow$3.7M+347%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$77.42M-43.0%
Enterprise value$72.37M-43.2%
P/E15.3×+1.4×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-2.8pp
Operating margin3.3%-2.0pp
Net margin2.8%-1.5pp
FCF margin3.7%-0.9pp

Returns & leverage

See full
Return on equity14.9%-17.5pp
Debt / equity0.3×0.0×
Current ratio1.9×0.0×

Segments

By product

See full
Protandim$19.1M-17.5%
Life Vantage Product Line$9.6M-44.8%
True Science Product Line$9.0M-20.0%
AXIO Product Line$4.2M-3.5%
Love Biome Product Line$2.9M—

By segment

See full
Reportable$42.4M-23.1%

FAQ

When did LifeVantage Corporation report Q4 2026 earnings?
LifeVantage Corporation (LFVN) reported Q4 2026 earnings on August 27, 2026 after market close.
What were LifeVantage Corporation's Q4 2026 revenue and EPS?
LifeVantage Corporation reported revenue of $42.4M and eps of $0.11 for Q4 2026.
Did LifeVantage Corporation beat estimates in Q4 2026?
Revenue missed the consensus estimate of $44.0M by $1.6M. EPS missed the consensus estimate of $0.12 by $0.01.
How did LifeVantage Corporation's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 23.1% from $55.1M a year earlier and eps declined 35.3% from $0.17.
Where can I find LifeVantage Corporation's Q4 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-371265) and the 10-K periodic report (0001193125-26-371257) directly on SEC EDGAR. The filing index links above go to sec.gov.